Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in Multiple Sclerosis and EAE

Brain, Behavior, and Immunity

Volumn 24, Issue 5, 2010, Pages 738-746

  Campbell, Sandra J ^a   Meier, Ute ^b   Mardiguian, Silvy ^a   Jiang, Yanyan ^a   Littleton, Edward T ^e   Bristow, Adrian ^c   Relton, Jane ^f   Connor, Thomas J ^d   Anthony, Daniel C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f BIOGEN   (United States)

Author keywords

Behaviour; Brain; Chemokine; Cytokine; Depression; Fatigue; Hypothalamus; Inflammation

Indexed keywords

ALPHA CHEMOKINE; BETA INTERFERON; CXCL1 CHEMOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; RECOMBINANT BETA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN TISSUE; ILLNESS BEHAVIOR; LIVER HISTOLOGY; MALE; MICROINJECTION; MORBIDITY; MOUSE; MULTIPLE SCLEROSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHEMOKINE CXCL1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; ILLNESS BEHAVIOR; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; INTERFERON-BETA; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIVER; MALE; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; NEUTROPHILS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953612883     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.01.011     Document Type: Article

References (38)

1. Andersson P.B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 1992, 48:169-186.
2. Anthony D., Dempster R., Fearn S., Clements J., Wells G., Perry V.H., Walker K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. 1998, 8:923-926.
3. Blond D., Campbell S.J., Butchart A.G., Perry V.H., Anthony D.C. Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain. Brain Res. 2002, 958:89-99.
4. Campbell S.J., Anthony D.C., Oakley F., Carlsen H., Elsharkawy A.M., Blomhoff R., Mann D.A. Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J. Neuropathol. Exp. Neurol. 2008, 67:223-230.
5. Campbell S.J., Hughes P.M., Iredale J.P., Wilcockson D.C., Waters S., Docagne F., Perry V.H., Anthony D.C. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 2003, 17:1168-1170.
6. Campbell S.J., Hughes P.M., Iredale J.P., Wilcockson D.C., Waters S., Docagne F., Perry V.H., Anthony D.C. CINC-1 is identified as an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 2003, 17:1168-1170.
7. Campbell S.J., Jiang Y., Davis A.E., Farrands R., Holbrook J., Leppert D., Anthony D.C. Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J. Neurochem. 2007, 103:2245-2255.
8. Campbell S.J., Perry V.H., Pitossi F.J., Butchart A.G., Chertoff M., Waters S., Dempster R., Anthony D.C. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am. J. Pathol. 2005, 166:1487-1497.
9. Campbell S.J., Wilcockson D.C., Butchart A.G., Perry V.H., Anthony D.C. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J. Neurochem. 2002, 83:432-441.
10. Carlson T., Kroenke M., Rao P., Lane T.E., Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 2008, 205:811-823.
11. Cartmell T., Luheshi G.N., Rothwell N.J. Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J. Physiol. 1999, 518(Pt. 2):585-594.
12. Danik M., Puma C., Quirion R., Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. J. Neurosci. Res. 2003, 74:286-295.
13. Dantzer R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North Am. 2009, 29:247-264.
14. Giovannoni G., Miller D.H., Losseff N.A., Sailer M., Lewellyn-Smith N., Thompson A.J., Thompson E.J. Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J. Neurol. 2001, 248:487-495.
15. Giovannoni G., Thompson A.J., Miller D.H., Thompson E.J. Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology 2001, 57:676-681.
16. Glabinski A.R., Tuohy V.K., Ransohoff R.M. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 1998, 5:166-171.
17. Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci. 2002, 205:51-58.
18. Jiang Y., Deacon R., Anthony D.C., Campbell S.J. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. 2008, 32:125-132.
19. Konishi K., Takata Y., Watanabe K., Date T., Yamamoto M., Murase A., Yoshida H., Suzuki T., Tsurufuji S., Fujioka M. Recombinant expression of rat and human Gro proteins in Escherichia coli. Cytokine 1993, 5:506-511.
20. Konishi K., Takata Y., Yamamoto M., Yomogida K., Watanabe K., Tsurufuji S., Fujioka M. Structure of the gene encoding rat neutrophil chemo-attractant Gro. Gene 1993, 126:285-286.
21. Laver T., Nozell S.E., Benveniste E.N. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9. J. Interferon Cytokine Res. 2008, 28:13-23.
22. Lechan R.M., Toni R., Clark B.D., Cannon J.G., Shaw A.R., Dinarello C.A., Reichlin S. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 1990, 514:135-140.
23. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 1996, 40:846-852.
24. Martin-Saavedra F.M., Gonzalez-Garcia C., Bravo B., Ballester S. Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells. Mol. Immunol. 2008, 45:4008-4019.
25. McCluskey L., Campbell S., Anthony D., Allan S. Inflammatory response in the brain in response to different methods of intra-cerebral administration. J. Neuroimmunol. 2008, 194:27-33.
26. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
27. Mellergard, J., Edstrom, M., Vrethem, M., Ernerudh, J., Dahle, C., 2009. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Mult. Scler.
28. Nguyen D., Stangel M. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res. Dev. Brain Res. 2001, 128:77-81.
29. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., French-Mullen J.M.b. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol. Behav. 1996, 60:867-875.
30. Porcel J., Rio J., Sanchez-Betancourt A., Arevalo M.J., Tintore M., Tellez N., Borras C., Nos C., Montalban X. Long-term emotional state of multiple sclerosis patients treated with interferon beta. Mult. Scler. 2006, 12:802-807.
31. Rovaris M., Barnes D., Woodrofe N., du Boulay G.H., Thorpe J.W., Thompson A.J., McDonald W.I., Miller D.H. Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J. Neurol. 1996, 243:536-542.
32. Skerra A., Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988, 240:1038-1041.
33. Smith D. Interferon-beta therapy for multiple sclerosis-is the injection site the relevant action site?. J. Neuroimmunol. 2009, 215:117-121.
34. Subileau E.A., Rezaie P., Davies H.A., Colyer F.M., Greenwood J., Male D.K., Romero I.A. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J. Neuropathol. Exp. Neurol. 2009, 68:227-240.
35. Valles A., Grijpink-Ongering L., de Bree F.M., Tuinstra T., Ronken E. Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival. Neurobiol. Dis. 2006, 22:312-322.
36. Wang H., Buchner M., Moser M.T., Daniel V., Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months. Clin. J. Pain 2009, 25:1-4.
37. Watson K., Fan G.H. Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol. Pharmacol. 2005, 67:757-765.
38. Wigmore S.J., Fearon K.C., Maingay J.P., Lai P.B., Ross J.A. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am. J. Physiol. 1997, 273:E720-E726.